Maya R Sternberg, Amelia Johnson, Justice King, Akilah R Ali, Lauren Linde, Abiola O Awofeso, Jodee S Baker, Nagla S Bayoumi, Steven Broadway, Katherine Busen, Carolyn Chang, Iris Cheng, Mike Cima, Abi Collingwood, Vajeera Dorabawila, Cherie Drenzek, Aaron Fleischauer, Ashley Gent, Amanda Hartley, Liam Hicks, Mikhail Hoskins, Amanda Jara, Amanda Jones, Saadiah I Khan, Ishrat Kamal-Ahmed, Sarah Kangas, Fnu Kanishka, Alison Kleppinger, Anna Kocharian, Tomás M León, Ruth Link-Gelles, B Casey Lyons, John Masarik, Andrea May, Donald McCormick, Stephanie Meyer, Lauren Milroy, Keeley J Morris, Lauren Nelson, Enaholo Omoike, Komal Patel, Michael Pietrowski, Melissa A Pike, Tamara Pilishvili, Xandy Peterson Pompa, Charles Powell, Kevin Praetorius, Eli Rosenberg, Adam Schiller, Mayra L Smith-Coronado, Emma Stanislawski, Kyle Strand, Buddhi P Tilakaratne, Hailey Vest, Caleb Wiedeman, Allison Zaldivar, Benjamin Silk, Heather M Scobie
BACKGROUND: SARS-CoV-2 Omicron variants have the potential to impact vaccine effectiveness and duration of vaccine-derived immunity. We analyzed U.S. multi-jurisdictional COVID-19 vaccine breakthrough surveillance data to examine potential waning of protection against SARS-CoV-2 infection for the Pfizer-BioNTech (BNT162b) primary vaccination series by age. METHODS: Weekly numbers of SARS-CoV-2 infections during January 16, 2022-May 28, 2022 were analyzed by age group from 22 U...
2023: PloS One